Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3163

1.

Correction: MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment.

Yuan H, Wang X, Lu J, Zhang Q, Brandina I, Alexandrov I, Glazer RI.

Oncotarget. 2018 Dec 28;9(102):37808. doi: 10.18632/oncotarget.26548. eCollection 2018 Dec 28.

2.

Correction: Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.

Wang LT, Chiou SS, Chai CY, Hsi E, Wang SN, Huang SK, Hsu SH.

Oncotarget. 2018 Dec 28;9(102):37807. doi: 10.18632/oncotarget.26547. eCollection 2018 Dec 28.

3.

Green tea extract for prevention of prostate cancer progression in patients on active surveillance.

Kumar NB, Dickinson SI, Schell MJ, Manley BJ, Poch MA, Pow-Sang J.

Oncotarget. 2018 Dec 28;9(102):37798-37806. doi: 10.18632/oncotarget.26519. eCollection 2018 Dec 28. Review.

4.

Precision medicine in the treatment stratification of AML patients: challenges and progress.

Lohse I, Statz-Geary K, Brothers SP, Wahlestedt C.

Oncotarget. 2018 Dec 28;9(102):37790-37797. doi: 10.18632/oncotarget.26492. eCollection 2018 Dec 28. Review.

5.

Genetic biomarkers predict response to dual BCL-2 and MCL-1 targeting in acute myeloid leukaemia cells.

Grundy M, Balakrishnan S, Fox M, Seedhouse CH, Russell NH.

Oncotarget. 2018 Dec 28;9(102):37777-37789. doi: 10.18632/oncotarget.26540. eCollection 2018 Dec 28.

6.

Neoadjuvant intra-arterial chemotherapy using an original four-lumen double-balloon catheter for locally advanced uterine cervical cancer.

Tanaka T, Terai Y, Fujiwara S, Tanaka Y, Sasaki H, Tsunetoh S, Yamamoto K, Yamada T, Ohmichi M.

Oncotarget. 2018 Dec 28;9(102):37766-37776. doi: 10.18632/oncotarget.26518. eCollection 2018 Dec 28.

7.

Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia.

Padgaonkar A, Rechkoblit O, Vasquez-Del Carpio R, Pallela V, Venkata Subbaiah D, Cosenza SC, Baker SJ, Ramana Reddy MV, Aggarwal A, Reddy EP.

Oncotarget. 2018 Dec 28;9(102):37753-37765. doi: 10.18632/oncotarget.26514. eCollection 2018 Dec 28.

8.

Divergent roles of lysyl oxidase family members in ornithine decarboxylase- and RAS-transformed mouse fibroblasts and human melanoma cells.

Kielosto M, Eriksson J, Nummela P, Yin M, Hölttä E.

Oncotarget. 2018 Dec 28;9(102):37733-37752. doi: 10.18632/oncotarget.26508. eCollection 2018 Dec 28.

9.

Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma.

Pestana RC, Hassan MM, Abdel-Wahab R, Abugabal YI, Girard LM, Li D, Chang P, Raghav K, Morris J, Wolff RA, Rashid A, Amin HM, Kaseb A.

Oncotarget. 2018 Dec 28;9(102):37721-37732. doi: 10.18632/oncotarget.26507. eCollection 2018 Dec 28.

10.

Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma.

Younes M, Ly CJ, Singh K, Ertan A, Younes PS, Bailey JM.

Oncotarget. 2018 Dec 28;9(102):37715-37720. doi: 10.18632/oncotarget.26503. eCollection 2018 Dec 28.

11.

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001.

Abrahams CL, Li X, Embry M, Yu A, Krimm S, Krueger S, Greenland NY, Wen KW, Jones C, DeAlmeida V, Solis WA, Matheny S, Kline T, Yam AY, Stafford R, Wiita AP, Hallam T, Lupher M, Molina A.

Oncotarget. 2018 Dec 28;9(102):37700-37714. doi: 10.18632/oncotarget.26491. eCollection 2018 Dec 28.

12.

Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.

Kikutake C, Yoshihara M, Sato T, Saito D, Suyama M.

Oncotarget. 2018 Dec 28;9(102):37689-37699. doi: 10.18632/oncotarget.26485. eCollection 2018 Dec 28.

13.

A comparison of prostate cancer bone metastases on 18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion.

Harmon SA, Mena E, Shih JH, Adler S, McKinney Y, Bergvall E, Mehralivand S, Sowalsky AG, Couvillon A, Madan RA, Gulley JL, Eary J, Mease RC, Pomper MG, Dahut WL, Turkbey B, Lindenberg L, Choyke PL.

Oncotarget. 2018 Dec 28;9(102):37676-37688. doi: 10.18632/oncotarget.26481. eCollection 2018 Dec 28.

14.

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer.

Pozo K, Zahler S, Ishimatsu K, Carter AM, Telange R, Tan C, Wang S, Pfragner R, Fujimoto J, Grubbs EG, Takahashi M, Oltmann SC, Bibb JA.

Oncotarget. 2018 Dec 28;9(102):37662-37675. doi: 10.18632/oncotarget.26480. eCollection 2018 Dec 28.

15.

A study of meiomitosis and novel pathways of genomic instability in cutaneous T-cell lymphomas (CTCL).

Tsang M, Gantchev J, Netchiporouk E, Moreau L, Ghazawi FM, Glassman S, Sasseville D, Litvinov IV.

Oncotarget. 2018 Dec 28;9(102):37647-37661. doi: 10.18632/oncotarget.26479. eCollection 2018 Dec 28.

16.

TNFα mediated ceramide generation triggers cisplatin induced apoptosis in B16F10 melanoma in a PKCδ independent manner.

Ghosh S, Jawed JJ, Halder K, Banerjee S, Chowdhury BP, Saha A, Juin SK, Majumdar SB, Bose A, Baral R, Majumdar S.

Oncotarget. 2018 Dec 28;9(102):37627-37646. doi: 10.18632/oncotarget.26478. eCollection 2018 Dec 28.

17.

piRNA-8041 is downregulated in human glioblastoma and suppresses tumor growth in vitro and in vivo.

Jacobs DI, Qin Q, Fu A, Chen Z, Zhou J, Zhu Y.

Oncotarget. 2018 Dec 28;9(102):37616-37626. doi: 10.18632/oncotarget.26331. eCollection 2018 Dec 28.

18.

The Janus face of rosiglitazone.

Pich C, Michalik L.

Oncotarget. 2018 Dec 28;9(102):37614-37615. doi: 10.18632/oncotarget.26532. eCollection 2018 Dec 28. No abstract available.

19.

Implantable biomaterials to provide local immunotherapy following surgical resection.

Gough MJ, Baird JR, Bell RB.

Oncotarget. 2018 Dec 28;9(102):37612-37613. doi: 10.18632/oncotarget.26487. eCollection 2018 Dec 28. No abstract available.

20.

Keeping CDK18 in balance to prevent DNA replication stress in breast cancer.

Braams E, D'Angiolella V.

Oncotarget. 2018 Dec 28;9(102):37610-37611. doi: 10.18632/oncotarget.26517. eCollection 2018 Dec 28. No abstract available.

Supplemental Content

Loading ...
Support Center